1. Colorectal cancer cells respond differentially to autophagy inhibition in vivo
   Annie Lauzier et al, 2019, Scientific Reports CrossRef
2. Polymorphisms within Autophagy-Related Genes Influence the Risk of Developing Colorectal Cancer: A Meta-Analysis of Four Large Cohorts
   Juan Sainz et al, 2021, Cancers CrossRef
3. The role of metabolic ecosystem in cancer progression — metabolic plasticity and mTOR hyperactivity in tumor tissues
   Anna Sebestyén et al, 2021, Cancer and Metastasis Reviews CrossRef
4. KPT-9274, an Inhibitor of PAK4 and NAMPT, Leads to Downregulation of mTORC2 in Triple Negative Breast Cancer Cells
   Emma Cordover et al, 2020, Chemical Research in Toxicology CrossRef
5. Role of mammalian target of rapamycin complex 2 in primary and secondary liver cancer
   Katharina Joechle et al, 2021, World Journal of Gastrointestinal Oncology CrossRef
6. Targeting mTOR and Metabolism in Cancer: Lessons and Innovations
   Cedric Magaway et al, 2019, Cells CrossRef
7. mTOR hyperactivity and RICTOR amplification as targets for personalized treatments in malignancies
   Dániel Sztankovics et al, 2024, Pathology and Oncology Research CrossRef
8. Regulation and metabolic functions of mTORC1 and mTORC2
   Angelia Szwed et al, 2021, Physiological Reviews CrossRef
9. Dual Inhibition of mTORC1/2 Reduces Migration of Cholangiocarcinoma Cells by Regulation of Matrixmetalloproteinases
   Katharina Joechle et al, 2022, Frontiers in Cell and Developmental Biology CrossRef